Researchers compared trends in the average weekly prescriptions of hydroxychloroquine/chloroquine, azithromycin, and 10 commonly used medications dispensed between February 16 and April 25, 2020 with those dispensed between February 17 and April 27, 2019.
Higher rates of decidual arteriopathy and other maternal vascular malperfusion features are seen in placentas of women with severe acute respiratory syndrome coronavirus 2.
Treatment with remdesivir was associated with a shorter time to recovery in patients hospitalized with coronavirus disease 2019 (COVID-19), according to peer-reviewed data published in the New England Journal of Medicine.
A recombinant adenovirus type-5 (Ad5) vectored COVID-19 vaccine is safe, tolerable, and immunogenic.
The FDA has approved Artesunate for Injection (Amivas) for the initial treatment of severe malaria in adult and pediatric patients.
The accuracy of the RT-PCR test depends on timing; tests are best given within 10 days of COVID-19 symptom development.
The American Hospital Association survey provided data to determine the availability of telemedicine services at US hospitals in 2019.
An international registry dedicated to pediatric patients with cancer infected with COVID-19 was made possible through an international collaboration.
COVID-19 spreads swiftly between people but is not easily caught from contaminated surfaces, according to updated information from the US Centers for Disease Control and Prevention.
Children may experience acute cardiac decompensation due to a severe inflammatory state following infection with severe acute respiratory SARS-CoV-2.
There is a lack of evidence supporting the use of dietary supplements for the prevention or treatment of COVID-19, despite what recent news or social media platforms have asserted,
The diagnostic specificity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serologic assays varies, and sensitivity is poor during the first 14 days of symptoms.
Epidemiologic, clinical, microbiologic and antimicrobial resistance (AMR) data on nosocomial superinfections during the coronavirus disease 2019 (COVID-19) pandemic is needed to inform stewardship.
Fifteen percent of pregnant women with COVID-19 have severe disease.
Researchers sought to provide an early description and characterization of COVID-19 infection in North American pediatric intensive care units.
In light of the changes inflicted by the COVID-19 pandemic, the researchers wished to explore the effects of the pandemic on stroke management during the first month of Italy’s lockdown.
Sociodemographic factors associated with the risk for a positive severe acute respiratory syndrome coronavirus 2 test result include deprivation, population density, and ethnicity,
The effects of reducing hyperinflammation by immunosuppression has been discussed in this editorial.
The Society of Gynecologic Oncology published recommendations to guide clinicians through shared decision making with patients about anticancer treatment.
In a joint guidance document, recommendations are presented for the management of osteoporosis during the COVID-19 pandemic.